Month: July 2015

July 21, 2015, by NCI Staff T-VEC, an oncolytic virus, works by infecting and killing tumor cells, like these dividing melanoma cells, and stimulating an immune response against cancer cells throughout the body. Credit: Wellcome Images, CC BY-NC-ND 4.0 In a phase III clinical trial, an investigational virus-based immunotherapy, talimogene laherparepvec (T-VEC), significantly increased the
0 Comments
July 17, 2015, by Malcolm Smith, M.D., Ph.D. Malcolm A. Smith, M.D., Ph.D.Associate Branch Chief, PediatricsNCI Cancer Therapy Evaluation Program Our understanding of the genetic changes underlying cancers in children has increased tremendously in the past decade, but there are still critical gaps in our knowledge. Recognizing the importance of closing these knowledge gaps to
0 Comments
July 15, 2015, by NCI Staff Exosomes containing the protein GPC1 could potentially be used to detect early signs of pancreatic cancer in blood, according to a new study. Credit: Macmillan Publishers Ltd, Nature Researchers have identified a potential biological marker for detecting pancreatic cancer in its early stages—a protein attached to vesicles that circulate
0 Comments
July 10, 2015, by NCI Staff NCI recently issued a new solicitation for research proposals under the Provocative Questions (PQ) Initiative, a program aimed at promoting cancer-related research on important yet understudied areas or research questions that have proven difficult to address. The most recent PQ Requests for Applications (RFAs)—RFA-CA-15-008 and RFA-CA-15-009—include 12 questions. Over
0 Comments
July 8, 2015, by Nelvis Castro For many, the word “cancer” requires no translation. A diagnosis—regardless of what language carries the message—can be devastating and the need for accurate information immediate. As a Latina who has worked in cancer communications for more than 25 years—with colleagues, journalists, researchers, and health care professionals around the world—I
0 Comments